• 3D metal printing for aviation industry forecast to surge into serial production in this decade
• SGLB is only provider of in-process, quality-assurance software that offers in-process solutions to primary industry roadblocks
• 3D printing is increasingly adopted at all levels of aviation industry through pressure by tier-1 suppliers such as GE Aviation, Rolls Royce and Honeywell

Opportunities in 3D metal printing for the aviation space are forecast to exceed $7 billion within the next decade (http://ibn.fm/4hVsi) as the industry moves past the prototype phase and scales to its full profit potential. Sigma Labs Inc. (NASDAQ: SGLB) is the only provider of quality-assurance software that aims to remove remaining impediments to profitability by solving in-process, quality-control issues.

Also referred to as additive manufacturing, the 3D metal printing process produces three-dimensional objects by sintering metals layer by layer through the use of computer-aided design (CAD) files. Variances in the additive manufacturing process prevent consistent quality and often result in rejected output during post-production inspections. Through its PrintRite3D(R) brand, SGLB is positioning itself as the go-to provider of solutions that promise to eliminate inefficiencies, save time and allow the industry to profitably scale.

Driven by large aviation-parts players such GE Aviation, Rolls Royce and Honeywell, the use of additive manufacturing is increasingly being adopted at all levels of the industry through pressure by these tier-1 suppliers. As more companies seek to leverage this opportunity, demand for innovative solutions promising to save time, refine the production process and prevent rejected output continues to increase.

As the sole provider of quality-control solutions, SGLB provides software that addresses these critical issues in two ways: first, by enabling real-time, in-process detection of manufacturing irregularities, and second, through the provision of error reporting that provides operators with critical, actionable information that enables them to address any developing anomalies during the production process. Since manufacturers currently cannot tell if design specifications are met until the end of the production process, SGLB’s software potentially reduces the rejected output and postproduction inspection times by allowing operators to monitor manufacturing in real time.

Founded by a team of Los Alamos National Labs scientists and engineers in 2010, Sigma Labs first operated as a developer of commercially licensed, advanced metallurgical products before entering the 3D-metal-printing space. Forecasting high demand for quality-control solutions in this area, the company has since focused on creating products and services geared toward highly demanding, precision-dependent companies in the aerospace, defense, transportation, oil and gas, and biomedical industries.

SGLB’s global client base includes many tier-1 OEM enterprises and end users, including Airbus, Baker Hughes and Pratt & Whitney. With current 3D metal industry annual revenues estimated at more than $1.4 billion, the addition of quality-assurance software to the commercial 3D-metal-printing industry is expected to help the industry toward its forecast growth to $3.9 billion by 2023. Referred to by many as the fourth industrial revolution, additive manufacturing has tremendous potential, assuming a primary impediment for scaling and profitability – quality control – can be overcome. SGLB is positioning itself as the premier provider of innovative software solutions that address this demand.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• SHRG focused on top 2020 health, wellness industry trends, including inclusivity
• Elepreneurs become part of strong community the moment they launch with Sharing Services
• Elepreneurs elevate lives of customers with products that increase happiness and health; produce consistent revenue gains quarter after quarter

In 2020, one of the hottest trends for the health and wellness industry is inclusivity. As barriers created by wealth, gender, race, and physical or mental capabilities are being broken down, those who have felt excluded from traditional approaches to health and wellness are finding a seat at the table. Customized solutions paired with commitment to encourage and support everyone on their wellness journeys are allowing people to shift from a culture of acclimation to one of true holistic self-care (http://ibn.fm/YEcgk). At Sharing Services Global Corporation (OTCQB: SHRG), inclusivity has always been at the core of the company’s health and wellness line.

SHRG is a diversified company operating through two primary subsidiaries: Elepreneurs Holdings and Elevacity Holdings. Elepreneurs is a direct-selling company that utilizes an international network of home-based entrepreneurs called Elepreneurs. Elevacity creates health and wellness products that promote happiness and well-being. Both subsidiaries were named to signify Sharing Service’s commitment to elevate lives – whether through business opportunities or through wellness products.

Elepreneurs are a group of men and women who share one common trait: they want to make entrepreneurship their primary career. Sharing Service’s commitment to each of its independent sales representatives is to elevate lives through products, services and business opportunities. At SHRG, everyone becomes part of a supportive community the moment they join.

SHRG truly believes it is only through serving and helping others succeed that its Elepreneurs will experience their own success. This service model has translated into significant, consistent growth over the past two years. In December 2019, the company once again reported increased revenues, with numbers totaling $38.9 million for its fiscal quarter ending October 31, 2019 (http://ibn.fm/oQfjx).

“Product sales for our incredible health and wellness products of Elevacity Global continue to be strong, consistently increasing each quarter,” SHRG CEO John “JT” Thatch stated in a news release. “Our Q2 revenues demonstrate that our sales and support strategies are on the right path as we continue to grow in the direct-selling marketplace. We attribute our success to our independent distributors, which we refer to as Elepreneurs, and our incredible team at the corporate offices.”

The service model SHRG utilizes to elevate Elepreneurs is the same one these individuals are taking to their clients. Elepreneurs are providing optimal service and elevating the lives of customers with products that increase happiness and health.

The Elevate health and wellness product line is referred to as D.O.S.E, which stands for dopamine, oxytocin, serotonin and endorphins. All four of these are key hormones proven to promote happiness and well-being. SHRG’s product line is designed to help increase happiness hormone levels for consumers. These carefully formulated products have one objective: to increase happiness and health.

Inclusivity deserves more than a 2020 trend title, and SHRG is committed to elevating the lives of everyone involved with the company – including entrepreneurs, customers and investors alike.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• Pharmaceutical services business Trxade Group Inc. recently announced its uplisting to the Nasdaq Capital Market and will ring the exchange’s opening bell this Friday, February 28, 2020
• The ringing of the opening bell will be broadcast live at 9:30 a.m. EST from the Nasdaq’s Times Square market site in New York City
• The company will cease trading on the OTC market and phase out its ‘TRXD’ ticker as part of the move, transitioning to new Nasdaq ticker ‘MEDS’
• Trxade Group is a pioneer in building a supplier-to-pharmacy platform that helps small, independent businesses be competitive with larger chains by sourcing drugs at discount prices, building consumer confidence through transparency in operations
• The company’s network of pharmaceutical partners continues to expand, aiming to eventually reach most, if not all, of the nation’s 24,000 independent pharmacies

Pharmacy services B2B innovator Trxade Group Inc. (NASDAQ: MEDS) will ring the Nasdaq opening bell Friday, February 28, to celebrate the supplier-to-pharmacy business’s uplisting to the Capital Market exchange, which the company announced February 13.

As one circumstance of the move, Trxade will begin trading under the ticker MEDS and will phase out its previously existing OTC common stock symbol, ‘TRXD’. The iconic ringing of the bell represents a significant milestone for companies and an opportunity for them to celebrate their achievements in front of a global audience. The bell ringing will be broadcast live via satellite at 9:30 a.m. from the Nasdaq’s Time Square market site in New York City, following an hour of lead-up promotional events with Nasdaq senior executives.

“We’ve been under the radar for a long time. We’re trying to create visibility among the investor base by doing the right thing,” CEO Suren Ajjarapu stated late last year following completion of an agreement between its subsidiary Bonum Health and Benzer Pharmacy to create a network of ‘Bonum Health Hub’ units in small towns and rural areas as part of the lead-up to the Nasdaq listing (http://ibn.fm/cO5VE).

The company recently completed a firm commitment public offering of 806,452 shares of its common stock following a voter-approved reverse stock split. Trxade expects to gain gross proceeds of $5.2 million from the sale of common stock in the offering, minus standard expenses tied to the offering.

Trxade Group relishes its role as a health care industry influencer intent on enabling price transparency and increased profit margins to health care buyers and sellers of pharmaceuticals, particularly the nation’s independent pharmacies that serve small, close-knit communities.

The company anticipates using the net proceeds of the public offering for its own general corporate purposes and possibly to fund acquisitions of other companies, products or technologies – part of Trxade’s strategy for increasing shareholder value and advancing its business model.

Trxade’s network of platform clients includes nearly 11,900 independent pharmacies registered and the company aims to continuously grow the size of the network until most, if not all, of the nation’s 24,000 independent pharmacies are represented with a combined annual purchasing power of more than $92 billion to help them compete with larger pharmaceutical companies.

“During the third quarter of 2019, we made excellent progress in our core proprietary B2B trading platform www.trxade.com, which enables independent pharmacies to purchase drugs at discount prices compared to their primaries, enabling us to experience top and bottom line growth,” Ajjarapu stated (http://ibn.fm/Yau0t). “Additionally, we are investing in core infrastructure for our B-to-C (Community Specialty Pharmacy) business in our wholesale, e-commerce and delivery capabilities as increasing pharmaceutical prices drive independent pharmacies, payors and consumers to be more aggressive in sourcing medication.”

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

• Aerospace 3D-printing market forecast to reach more than $3 billion in 2022
• Industry expert calls in-process quality control “one of the most promising developments in metal ALM production”
• SGLB technology represents paradigm shift in quality-control process for manufacturing of 3D-printed metal components

The additive marketing, or 3D printing, industry is flying high in the aerospace sector. A Research and Markets study reported the aerospace 3D printing market is expected to grow from $714.5 million in 2017 to $3,057.9 billion by 2022 — a CAGR of 27.42% (http://ibn.fm/ly23w). Those numbers could go even higher as quality-assurance obstacles that have impeded the full adoption of 3D metal printing are successfully eliminated by Sigma Labs Inc. (NASDAQ: SGLB), the only provider of in-process, quality-assurance software to the commercial 3D-metal- printing industry.

“Aerospace has a long history of latest technology inventions’ early adopter and ultimate trendsetter in manufacturing,” according to an article by Farinia Group – a manufacturing organization dedicated to material transformation using state-of-the art equipment, know-how and technical expertise (http://ibn.fm/qeUsL). “New materials, state-of-the-art manufacturing processes and sophisticated software were created and absorbed by this industry decades ago and are now common for other industries.”

The Farinia Group noted several advantages of 3D printing in the aerospace sector, including the following:

• Shorter development process and time to market
• Freedom to design complex geometries, leading to maximized performance, consolidated design, improved reliability, and improved fuel efficiency
• On-demand and on-site spares manufacturing
• Higher material efficiency
• Reduced costs for certain components
• In-process quality assurance reducing overall lead time

It is in this last area – in-process quality assurance – where Sigma Labs shines. The company’s proprietary PrintRite3D® software is the singular solution that enables real-time, in-process detection of manufacturing irregularities for critical metal parts. The technology then provides the operator with the information and ability to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality-control process for the manufacture of 3D printed metal components. The company is the only provider of in-process quality-assurance software to the commercial 3D-metal-printing industry offering these capabilities.

“Aerospace, as an industry obsessed by performance and reliability, has since long performed quality-assurance downstream to manufacturing,” the Farinia Group article continues. “A critical stage for aerospace manufacturers in which any serial production often have to meet high specifications to satisfy stringent applications with high quality to ensure reliability. Insomuch that quality assurance can account significantly in the overall lead time and overall cost.”

In its report, the Farinia Group noted that “one of the most promising developments in metal ALM (additive layer manufacturing) production systems concerns the real-time and closed-loop in-process quality control…Monitoring the system settings and process parameters during the ongoing manufacturing permits to regulate and optimize conditions… In-process inspection of the material health and dimensional accuracy will surely unlock the power of ALM technology for serial aerospace production as qualification and consistency variation are now the main concerns.”

Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time, computer-aided-inspection (CAI) solutions known as PrintRite3D for 3D advanced manufacturing technologies. SGLB’s advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production – uniquely allowing errors to be corrected in real time.

For more information about Sigma Labs, please visit www.SigmaLabsInc.com

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://ibn.fm/SGLB

• Nightfood’s unique and healthier nutritional formulation best aligns with specific nutritional needs of pregnant women
• OBGYNs and other pre-natal caregivers have begun to introduce Nightfood ice cream to their pregnant patients and clients for pregnancy-related ice cream cravings
• Nightfood is establishing leading position in $50-billion, nighttime-snacking category

With more than three million women pregnant at any given time in the United States, Nightfood Holdings Inc. (OTCQB: NGTF) formal endorsement as the official ice cream of the American Pregnancy Association (http://ibn.fm/taOUi) signifies an important milestone. The award-winning ice cream company is committed to solving America’s $50-billion nighttime snacking problem and is earning recognition in other areas of excellence along the way.

“The buzz on social media about Nightfood has been building, and we noticed an increase in posts from pregnant women,” Nightfood CEO Sean Folkson stated in a news release explaining the background behind the company’s newest accolade. “Consulting with our nutrition experts, we discovered that Nightfood’s unique formulation, among all other ice creams on the market, best aligns with the specific nutritional needs women have during pregnancy. Objectively, Nightfood is the single most appropriate ice cream for moms-to-be and their cravings. This fact has now been confirmed and endorsed by the American Pregnancy Association.”

A national health organization committed to promoting reproductive and pregnancy wellness through education, support, advocacy and community awareness, the American Pregnancy Association (APA) currently serves over five million women and families a month through its website and toll-free education helpline.

“Over 130,000 visitors daily turn to the APA website for information about pregnancy health, nutrition, preparing for the birth experience, naming their baby, and more,” said APA president Lynn Handley. “We’re thrilled to be able to recommend Nightfood for those cravings that inevitably hit for most women. With more protein, fiber, calcium, magnesium, and less sugar, fewer calories, and ingredients to tackle nighttime heartburn, Nightfood is a more nutritionally appropriate ice cream for pregnant women than anything we’ve ever seen on the market, based on recommendations from the American College of Obstetrics and Gynecology, the Mayo Clinic, and general expert consensus on prenatal nutrition.”

With ice cream being the food most associated with pregnancy cravings, the APA recommendation represents a major endorsement for the flourishing ice cream company. “This groundbreaking endorsement is going to make for a busy 2020,” said Nightfood’s sales director Jessie Trinchard. “Nightfood has already secured distribution in major divisions of both Kroger and Albertsons, and we’re talking to additional national and regional chains. Now that we’re the official ice cream of pregnant women everywhere, it’s difficult to imagine significant chains not including Nightfood in their ice cream assortment.”

“With ice cream being pretty much synonymous with pregnancy cravings, I think it’s great that there’s finally an ice cream brand that I can confidently recommend to my patients,” added Dr. Jill Hechtman, MD, FACOG OB/GYN. “Nutrition and sleep play an important role in every pregnancy. And now so can Nightfood ice cream.”

Of course, the benefits of a delicious and nutritious ice cream extend well beyond pregnancy. While APA has named the Nightfood treat as the best ice cream for pregnant women, that distinction is only an added benefit for the company that initially designed its product as a healthier, sleep-friendly nighttime snack for everyone. Nightfood is fast establishing the leading position in the nighttime-snacking category where American consumers are generally dissatisfied with their choices yet are still spending more than $50 billion annually.

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• SPRWF partners with humble+fume to offer complete cannabis solution to cannabis retailers
• Agreement achieves coast-to-coast coverage with 14 sales professionals managing relationships at a store level
• Supreme Cannabis accelerate revenue generation with plan to introduce new consumer-facing brands at all key price points

Across Canada, a growing number of retail stores are opening as more and more cannabis consumers are opting to purchase cannabis products in store where they can view products and benefit from budtender recommendations. With this in mind, The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a company dedicated to growing the world’s best cannabis and becoming a leader in the global cannabis industry, has signed a landmark sales agency agreement with humble+fume, one of North America’s leading distributors of cannabis accessories (http://ibn.fm/gnGWv).

With the cannabis industry growing at an impressive rate, savvy cannabis companies recognize the power of having a strong, credible retail presence. SPRWF’s new agreement calls for humble+fume to act as the exclusive sales agent for Supreme Cannabis Company’s recreational products across Canada, achieving coast-to-coast coverage while, at the same time, creating an appealing sales proposition for retailers. The partnership establishes the only sales force in Canada able to offer a full cannabis solution that includes the sale of both cannabis and cannabis accessories – which are known as high-margin items for retailers.

“humble+fume is excited to have been chosen by Supreme Cannabis to be their coast-to-coast sales solution partner,” humble+fume CEO Bob Ritchot stated in a news release. “With the rapid expansion of retail outlets in Canada, this well-timed sales agent agreement enables us to accelerate our retailer market coverage and build on our existing distribution to 85% of cannabis retailers across Canada.”

The agreement calls for humble+fume to build Supreme Cannabis Company’s brands at a retail store level. humble+fume will begin with a 14-member team of experienced sales professionals dedicated to distributing SPRWF’s brands and educating budtenders on SPRWF’s products. By introducing brands with high-quality products at every key price point, team members will be able to address more consumer experiences and capture greater market share – ultimately driving distribution, brand advocacy and budtender education.

SPRWF offers a powerful portfolio for the team to promote. SPRWF brands cater to diverse consumer experiences, with a wide range of products that address recreational, wellness, medicinal and new consumer preferences. The company’s brand portfolio includes 7ACRES, Blissco, Truverra, Sugarleaf and Khalifa Kush Enterprises Canada. Under these brands, Supreme Cannabis has introduced and will continue to launch a diverse range of products, including cannabis flower, pre-rolls, vaporizer products, concentrates, and THC and CBD oils.

The Supreme Cannabis Company’s brands and products are complementary to humble+fume’s existing product portfolio, which includes Fume Labs’ superior line of cannabis concentrate and solventless products as well as a deep list of leading brands in the accessory category, including RYOT, GRAV, PULSAR and Canadian Lumber. Moving forward, both companies will also be looking for opportunities to strengthen the partnership by adding other complementary cannabis brands to the mix.

The Supreme Cannabis Company is a global, diversified portfolio of distinct cannabis companies, products and brands. Since 2014, SPRWF has emerged as one of the world’s fastest-growing, premium plant-driven lifestyle companies. Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including scaled cultivation, value-add processing, centralized manufacturing and product testing and research and development.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• The company has filed six patents on hemp extract technologies and delivery systems
• Expanding on development of infusion technologies to include exotic cannabinoids that may improve sleep and control appetite
• Industrial hemp market is expected to grow to $26.6 billion by 2025

Hemp infusion technology innovator MCTC Holdings Inc. (OTC: MCTC) appointed cannabis industry veteran Robert L. Hymers III as its chief financial officer. Previously a director of the company, Hymers has a vast and impressive background in financial planning and analysis, corporate finance, treasury, tax, investor relations, risk management, and strategic planning, according to a company press release (http://ibn.fm/dv67W).

Previously, Hymers was CFO and Director of Marijuana Company of America, Inc. (OTCQB: MCOA), and brings with him a deep understanding of the hemp and cannabis industries. MCTC and Marijuana Company of America have signed a distribution contract for MCTC’s Hemp You Can Feel(TM) beverage product line, a patent-pending, organic, ultra-clean label line of CBD powdered drink and hemp extract mixes (http://ibn.fm/7S07V).

According to MCTC CEO Arman Tabatabaei, the new appointment will significantly strengthen the company. Hymers “brings a unique combination of financial knowledge, executive insight and managerial talent that will help us not only in financial reporting and compliance, but also relative to both strategic planning and tactical execution,” as Tabatabaei noted in a news release.

On occasion of the appointment, Hymers commented that MCTC is bringing unique intellectual property to the cannabis and hemp extract marketplaces and beginning to introduce highly innovative products based on the company’s intellectual property. “It’s an exciting time in the marketplace and I am looking forward to helping the Company achieve its objectives while seeking to maximize shareholder value,” he added.

MCTC Holdings, which has announced a pending name change to Cannabis Global, is poised to take advantage of opportunities in the cannabis industry while avoiding overcrowded and potentially problematic niches like retail and cultivation. The company was reorganized in June 2019 and its rebranding has focused on developing unique cannabis-related intellectual properties, products and technologies. The company aims to process hemp isolates, distillates, and other refined products using special patent-pending delivery systems and sell them through food, beverage and consumer brands.

Through 2020, the company plans to conduct trials on exotic and lesser-known cannabinoids like cannabinol (CBN) and THC-V, including their potential effects on appetite suppression.

MCTC Holdings recently filed six patents, of which its fourth cannabinoid delivery technology patent is the most important for cannabinoid delivery systems. This patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium (http://ibn.fm/kw1UC).

As an integrated cannabis business operation and cannabinoid science innovator, MCTC Holdings is primarily focused on high-growth and high-margin sub-sectors of the cannabis and hemp industry, including multiple growing verticals in the global cannabis and industrial hemp markets via acquisitions, partnerships and the development of new intellectual property. According to a Research and Markets report, the global industrial hemp market is poised to grow exponentially, from $4.6 billion in 2019 to $26.6 billion by 2025, recording a CAGR of 34% (http://ibn.fm/ChYAV).

For more information, visit the company’s website at www.CannabisGlobalInc.com

NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC

• Many cannabis companies have struggled with declining investor interest amid product delivery shortfalls and adverse revenue reports
• The distribution obstacles have exacerbated company concerns by creating choking points for inventory, which can quickly lose potency in storage
• Lexaria Bioscience’s trademarked DehydraTECH powder-creating technology helps preserve cannabinoid effectiveness and extend storage potential 2 to 3 years
• The DehydraTECH platform also provides a key benefit in making cannabinoids, nicotine, NSAIDs and other drug products bioavailable as rapidly as inhaled products
• An alternative to inhaled smokes and vapes could provide health and wellness benefits to consumers by eliminating harm to users’ lungs
• Lexaria’s licensing strategy also enables other companies to utilize DehydraTECH’s IP in their products

As the cannabis industry works to weather 2019’s adverse profit and productivity reports (http://ibn.fm/niYkO), consumption drug platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is helping to ensure that product inventories can remain potent and perform at their potential despite a natural tendency for cannabinoids to deteriorate with time.

Public market investors have been short-term allies in a fledgling industry seeking long-term commitment, in large part because of initial sky-high expectations for profits from cannabis-related industries and regulatory hurdles from government oversight of a once-illegal product that have kept the brakes on runaway commerce. As a result, many companies have built up outsized debt-revenue ratios (http://ibn.fm/G29Ig).

Added to those concerns, a European study determined that the potency of tetrahydrocannabinol (THC) and cannabidiol (CBD) tends to degrade over time – THC by 20 percent per year while in storage and CBD by 10 percent (http://ibn.fm/3Dj6d), ensuring a need for producers to get their products to market in a timely fashion. Additionally, a study of storage mediums used for THC found that certain types of packaging can contribute to the degradation of the extract’s potency (http://ibn.fm/w0INv).

The adverse factors have combined to create a potential source of caution among consumers as some companies have had to report multi-million-dollar losses due to “congested inventory channels” resulting from production that has exceeded sales (http://ibn.fm/gbogP).

Lexaria’s product-stabilizing DehydraTECH(TM) oral drug delivery IP turns cannabis and hemp oils into powders that preserve the cannabinoid extracts in the products while mitigating microbiological growth to help the products last longer on retail shelves – the company reports (http://ibn.fm/KEyQ4) that products can be stored for two to three years and experience “reduced loss of cannabinoids compared to current industry practices.”

DehydraTECH’s primary benefit is that it enables swallowed drug substances to deliver their intended effects as rapidly and effectively as inhaled products such as smokes or vapes. Many consumers continue to prefer inhaling products containing nicotine-rich tobacco or cannabis-based marijuana and CBD, acknowledging that they get a quicker, better response than if they try to use other medicinal/wellness delivery methods.

The dangers of inhaling drug substances into the lungs have been established over decades, with recent concerns about vape ingredients adding new fuel to the fire (http://ibn.fm/ncC40). Lexaria is committed to combatting the deleterious effects of drug inhalation by making swallowed drug products more rapidly bioavailable in the bloodstream, and thereby as attractive as inhaled products if not more so.

In addition to the DehydraTECH products Lexaria markets, the company also licenses its technology to other companies for them to use in all of their edible and topical cannabis and/or hemp extract processing needs. Lexaria is able to process 250,000 servings of CBD at 10 mg each per day currently for distribution across the country.

Although CBD-based wellness products continue to remain under scrutiny by the federal government, many states have legalized topical and edible uses. A recent licensing agreement between Lexaria and the smokeless Cannadips CBD brand is drawing on DehydraTECH’s IP for a product chain available nationally through Circle K convenience outlets, in about 5,000 stores throughout the United States.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• PLUS targets new consumer demographics as it eyes wellness/relief and get-high, have-fun spaces
• Company has established reputation for providing top-selling, quality edibles

In the wake of a cannabis competitor losing its license, hemp and cannabis food company Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is reiterating its commitment to quality production as it gears up to launch a new line of products to supplement its already top-selling edibles. PLUS has announced plans to expand its brand portfolio in Q1 2020 as the cannabis-savvy company targets consumers outside of its core demographic (http://ibn.fm/Y7ciD).

Plus Products’ commitment to quality is particularly meaningful following the news that California cannabis regulators have revoked the business license of vaporizer brand Kushy Punch after the company was found to be operating from an unlicensed facility (http://ibn.fm/TMgbO). Not only does this news shine a spotlight on the importance of high-quality, compliant operations – a standard PLUS has maintained from day one – the license revocation may open up a void in the recreational cannabis space, which is where one of PLUS’s new product lines is targeting.

According to the company’s investor presentation, PLUS expects to release two new lines this year: one falling in the get-high, have-fun space and one falling in the wellness/relief category. Specific details are still to come, but PLUS has built a reputation for producing superior products that become top sellers within months of release.

Taking the world’s largest legal cannabis market by storm, the company’s flagship iconic gummy product – PLUS Uplift Sour Watermelon – headed up the 2019 list of California’s best-selling cannabis products, according to BDS Analytics. Furthermore, when PLUS released its edibles gummy line in Nevada in October 2019, the brand reached the number two spot in the gummies space in just over a quarter.

Plus Products is well positioned for greater growth in the United States and beyond. In addition to expanding into Nevada, the company is eyeing other U.S. markets, including Michigan, Arizona, Massachusetts, New York and Illinois, as well as actively exploring international partnerships to build a global brand. Of note for investors is that PLUS has a strong management team and a clean capital structure with considerable insider ownership. The company continues to build the world’s largest cannabis brand by taking a successful formula to new markets, products and consumers.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Cannabis industry saw 45.7% increase in legal cannabis sales last year
• Interview with PLUS highlights strong start to 2020
• Building a brand in largest competitive market has proven company quality and standards; setting up expansion into new markets

Legal cannabis spending worldwide increased from $10.2 billion in 2018 to $14.9 billion in 2019, making for a 45.7% increase driven primarily by the adult-use markets, reports the Arcview Group, a market research firm that specializes in cannabis. Arcview is now forecasting sales worldwide to reach $42.7 billion by 2024. This is exciting news for Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), an edible cannabis company that has sustained its position of number one gummy brand for more than six quarters in California, one of the most competitive cannabis markets in the world.

“The possibilities are boundless as political progress opens up more markets across the world, and struggling markets sort out their regulatory framework,” Troy Dayton, founder and chief strategy officer at the Arcview Group, stated in a news release (http://ibn.fm/ZVAcU).

Blake Brennan, head of investor relations for PLUS, recently spoke with Stuart Smith on NetworkNewsAudio. The interview highlights how 2020 is already proving to be a strong year for the company as it takes proven techniques and expands to new markets (http://ibn.fm/6nvsa).

PLUS was one of the first brands to bring fully compliant products to the California Adult-Use market and quickly grew into one of the leading edible brands in California. The company operates with the belief that everyone deserves access to consistent, doseable and delicious cannabis products. PLUS produces to scale through the thoughtful collaboration of experts that span many fields.

From day one, Plus Products’ strategy for growth was to build a brand and product in the largest competitive market and achieve success before moving to new markets. After six quarters with a product sitting at California’s top spot, PLUS has proven to the consumer its commitment to superior products. PLUS Uplift sour watermelon gummy was the best-selling cannabis product in California, and PLUS was the largest infused-gummy brand over that time period. However, the company has eyes to further prove itself to a larger market. Looking forward, the company has set its sights on becoming the world’s strongest cannabis brand portfolio (http://ibn.fm/Xlp3a).

With that goal in mind and with its products available in over 300 licensed retailers across California, PLUS made its move. In Q3 2019, the company unveiled a website featuring a new product line of 100% hemp, CBD-infused gummies that are available online in more than 40 states, and in Q4 2019, PLUS launched its best-selling product line in Nevada.

When Smith asked Brennan to highlight major milestones for 2019, Brennan responded by mentioning the following:

• Launching into two new markets – Nevada and CBD
• Solidifying PLUS’s position in California
• Sustaining the position of number one gummy brand for over six quarters
• Navigating a hypergrowth industry in a competitive market
• Recruiting key players and a strong management team

“Creating the dominance we have here in California in the new markets that we’ve just entered, Nevada and the hemp CBD market, is at the top of our list,” added Brennan. “Even though we’ve seen some early traction in those markets, we haven’t reached the status of the #1 gummies brand yet, but that is certainly our target with any market that we enter. We want to turn that traction into dominance.”

Expansion efforts into other states where cannabis is recreational is already a topic of conversation for PLUS. Looking forward, PLUS will start looking into further expansion efforts where cannabis is recreational. Michigan, Massachusetts and Illinois currently sit at the top of that list.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLUS